BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Reports

NEXT Life Sciences Advances Two Non Hormonal Male Contraceptives Into Phase II Trials

Men have long been waiting for new male contraceptive options outside of just condoms and vasectomy. Non-hormonal methods at the forefront of male interest...

February 23, 2026 | News

YolTech Reports Positive Interim Data For YOLT 202 In Alpha 1 Antitrypsin Deficiency

Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated with ...

February 23, 2026 | News

Takeda Reports Positive Phase 3 KEPLER Data For ENTYVIO In Pediatric Ulcerative Colitis

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate response to either conven...

February 23, 2026 | News

P Cure Reports First Prospective Clinical Evidence Supporting Gantry Less Upright Proton Therapy For Lung Cancer Re Irradiation

P-Cure, a supplier of compact, gantry-less proton therapy systems, announced the first-ever prospective clinical results demonstrating the feasibility, saf...

February 18, 2026 | News

Eli Lilly And Company Reports Statistically Significant Event Free Survival Benefit With Selpercatinib In Early Stage RET Fusion Positive NSCLC

Selpercatinib demonstrated a highly statistically significant and clinically meaningful improvement in reducing the risk of disease recurrence or deat...

February 18, 2026 | News

Jyong Biotech Strengthens Preventive Medicine Position With Positive Phase II Data And Asian Expansion

Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modul...

February 16, 2026 | News

QIAGEN Study Shows QuantiFERON TB Gold Plus Improves Cost Effectiveness Of HIV TB Screening In Thailand

Peer-reviewed health-economic analysis evaluates tuberculosis infection (TBI) screening strategies among people living with HIV in Thailand Quanti...

February 13, 2026 | News

Ascletis Advances ASC36 Oral Amylin Tablet With Strong Preclinical Weight Loss Data

Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady...

February 12, 2026 | News

Kirin Holdings And Immunosens Launch Joint Development Of Immune Self Testing Service

Kirin Holdings Company, Limited (Kirin Holdings) and Immunosens Co., Ltd. (Immunosens) have begun the joint development of a unique “Self-Testing Ser...

February 11, 2026 | News

Aucta Pharmaceuticals Launches PYQUVI Oral Suspension For Duchenne Muscular Dystrophy In The US

Aucta Pharmaceuticals is pleased to announce the late January launch of PYQUVI oral suspension 22.75 mg/mL. PYQUVI, a corticosteroid indicated f...

February 10, 2026 | News

Kelun Biotech Wins China Approval For Sacituzumab Tirumotecan In Advanced Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-dir...

February 09, 2026 | News

New England Biolabs Showcases Automation Ready NGS Workflows Through Global SLAS Collaborations

New England Biolabs (NEB ®) will present several scientific posters at this week's Society for Laboratory Automation and Screening (SLAS) meeting in Bo...

February 09, 2026 | News

Kazia Therapeutics Advances First In Class Nuclear PD L1 Protein Degrader With Compelling Preclinical Evidence

Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, announced co...

February 02, 2026 | News

Skyhawk Therapeutics Reports Positive Nine Month Interim Data For SKY 0515 In Huntington’s Disease

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural hi...

January 29, 2026 | News

Stay Connected